Facilitators and barriers for RhD-immunised women to become and remain anti-D donor

Selection and retention of anti-RhD immunoglobulin (anti-D) plasma donors is important to keep up the national prevention program of RhD-immunisation and subsequent haemolytic disease of the fetus and newborn (HDFN) in RhD-negative pregnant women. The Dutch prevention programme is very successful in reducing complications in pregnancies of RhD-negative women. Anti-D is produced by Sanquin from the plasma of a small group of donors, mostly women who have been RhD-immunised during or after pregnancy. More insight in facilitators and barriers for RhD-immunised women to donate plasma for anti-D production is of utmost importance to retain existing and recruit new anti-D donors and guarantee an ongoing production of anti-D from Dutch voluntary donors.